PUBLISHER: BCC Research | PRODUCT CODE: 1147907
PUBLISHER: BCC Research | PRODUCT CODE: 1147907
The global market for wireless medical device connectivity is estimated to increase from $1.7 billion in 2022 to $5.0 billion by 2027, at a compound annual growth rate (CAGR) of 24.0% from 2022 through 2027.
North American market for wireless medical device connectivity is estimated to increase from $604.0 million in 2022 to $1.9 billion by 2027, at a CAGR of 25.4% from 2022 through 2027.
Asia-Pacific market for wireless medical device connectivity is estimated to increase from $402.6 million in 2022 to $1.4 billion by 2027, at a CAGR of 27.9% from 2022 through 2027.
In this report, wireless medical device connectivity has been segmented based on offering, wireless connectivity type, end user, application, and geography. The report provides an overview of the global wireless medical device connectivity market and analyzes the market trends. It considers 2021 as the base year of 2021 and provides estimates for 2022 to 2027. Revenue forecasts from the period for segmentation based on the offering, wireless connectivity type, application, end-user, and geography have been estimated with values derived from manufacturers' total revenues.
The report also includes a section on the major players in the market. Further, it explains the major drivers, competitive landscape, and current trends for wireless medical device connectivity solutions. The report concludes with a detailed focus on the wireless medical device connectivity landscape and includes detailed profiles of the major players operating in the global wireless medical device connectivity market.
Medical device connectivity refers to maintaining connections between medical equipment. It eliminates the possibility of human error. Consequently, data can be transferred between devices more quickly and accurately. The scope of the study includes only wireless medical device connectivity solutions from the three available connectivity types: wired, wireless, and hybrid. These solutions are widely used for diseases that require continuous monitoring, including diabetic patients, cancer patients, asthmatics, etc.